Published in Carcinogenesis on July 05, 2007
Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci (2009) 3.27
Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res (2009) 1.04
The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology (2013) 1.00
STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation. J Neurosci (2012) 0.87
Pharmaceutical regulation of telomerase and its clinical potential. J Cell Mol Med (2012) 0.83
Therapeutic targeting of replicative immortality. Semin Cancer Biol (2015) 0.83
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene. Genes (Basel) (2016) 0.79
Isoflavones and Prostate Cancer: A Review of Some Critical Issues. Chin Med J (Engl) (2016) 0.79
Disruptive chemicals, senescence and immortality. Carcinogenesis (2015) 0.78
The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies. JAKSTAT (2013) 0.77
Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein. Nutr Cancer (2016) 0.76
Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res (2010) 1.95
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation. Biochem Biophys Res Commun (2007) 1.05
Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res (2009) 1.04
Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Carcinogenesis (2007) 1.01
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res (2006) 1.01
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. J Clin Invest (2013) 0.96
Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer (2013) 0.94
Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle (2010) 0.91
Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft. J Med Chem (2010) 0.87
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. PLoS One (2013) 0.87
Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate (2006) 0.87
Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem Biophys Res Commun (2007) 0.86
Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells. Biochem Biophys Res Commun (2007) 0.86
Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases. Prostate (2006) 0.85
Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha. Biochem Biophys Res Commun (2006) 0.84
A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells. Mol Cancer Ther (2013) 0.83
Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commun (2006) 0.82
The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog (2012) 0.79
Non-radioactive assay methods for the assessment of telomerase activity and telomere length. Methods Mol Biol (2009) 0.78
Use of structured light in 3D reconstruction of transparent objects. Appl Opt (2022) 0.75
Non-recursive transport of intensity phase retrieval with the transport of phase. Appl Opt (2022) 0.75
Digital tomographic compressive holographic reconstruction of three-dimensional objects in transmissive and reflective geometries. Appl Opt (2013) 0.75
Recursive method for phase retrieval using transport of intensity and its applications. Appl Opt (2016) 0.75
Digital Holography and 3D Imaging: introduction to the joint feature issue in Applied Optics and Journal of the Optical Society of America A. J Opt Soc Am A Opt Image Sci Vis (2022) 0.75
Application of up-sampling and resolution scaling to Fresnel reconstruction of digital holograms. Appl Opt (2015) 0.75
Non-radioactive assay methods for the assessment of telomerase activity and telomere length. Methods Mol Biol (2015) 0.75
Erratum: PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion. Oncotarget (2016) 0.75
Beam shaping by use of hybrid acousto-optics with feedback. Appl Opt (2005) 0.75
Gaussian-beam-induced photorefractive birefringence and its application to radio-frequency signal excision. Opt Lett (2002) 0.75
Digital Holography and 3D Imaging: introduction to the joint feature issue in Applied Optics and Journal of the Optical Society of America A. Appl Opt (2022) 0.75
Digital Holography and 3D Imaging: introduction to the joint feature issue in Applied Optics and Journal of the Optical Society of America B. Appl Opt (2017) 0.75